2022年11月21日 · Imago is a clinical stage biopharmaceutical company developing new medicines for the treatment of myeloproliferative neoplasms (MPNs) and other bone marrow diseases.

2022年11月22日 · Imago是一家专注血液和骨髓肿瘤研究的创新医药公司，开发治疗骨髓增生性肿瘤和其他骨髓疾病，总部位于美国加州旧金山湾区，当前已经拥有一款用于治疗相关肿瘤的尚在试验阶段的药物bomedemstat。

Imago BioSciences Inc is a clinical-stage biopharmaceutical company discovering and developing novel small molecule product candidates that target lysine-specific demethylase 1 (LSD1), an enzyme that plays a central role in the production of blood cells in the bone marrow.

2022年11月28日 · Merck, known as MSD outside of the United States and Canada, announced its intention to acquire Imago BioSciences, a clinical-stage biopharmaceutical company …

Imago BioSciences Announces Upcoming Presentations on Updated Data from Phase 2 Studies of Bomedemstat for the Treatment of Essential Thrombocythemia and Myelofibrosis at the 27th Congress of the European Hematology Association (EHA) for 2022 | Imago BioS

2023年1月12日 · Merck intends to complete today the acquisition of Imago through a merger of Merck’s wholly owned subsidiary with and into Imago, with Imago being the surviving corporation, in which all shares not tendered into the offer will be cancelled and converted into the right to receive cash equal to the $36.00 offer price per share, without interest ...

The IMAGO AIOS Lite smart boards enhance connections both in the classroom and the boardroom, seamlessly integrating essential interactive elements for real-time collaboration between teachers and students as well as team members. Here is an economical solution without sacrificing quality.

Imago BioSciences, Inc. is a drug discovery and clinical development company focused on the treatment of bone marrow disorders. The key product candidate is bomedemstat currently being clinically tested for the treatment of essential thrombocythemia (ET), polycythemia vera (PV) and myelofibrosis (MF).

- IMAGO AIOS Lite 是一款入门级交互式智能板，其简单直观的界面可满足用户的基本需求。 AIOS Lite 专为易于安装和使用而设计，具有增强参与度、提高工作效率和经济实惠的解决方案等优势。

Annuellement Imago Bio commercialise plus de 11 000 tonnes de fruits et légumes. Ses produits phares du printemps et de l’été sont les légumes ratatouille, l’artichaut, l’asperge, la patate douce, la pomme de terre primeur et des fruits comme la fraise, le melon, la figue et les fruits à noyaux.